Brief Communication of Assessment of Clinical Practice Regarding Pharmacological Treatment of Epilepsy: A Survey of Neurologists in Republic of Macedonia

1. Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe 2010. http://www.ibe-epilepsy.org/downloads/EURO%20 Report%20160510.pdfSearch in Google Scholar

2. Malmgren K, Flink R, Guekht AB, et al. ILAE Commission of European Affairs Subcommission on European Guidelines 1998-2001: The provision of epilepsy care across Europe. Epilepsia. 2003; 44(5): 727-731.10.1046/j.1528-1157.2003.58402.xSearch in Google Scholar

3. Wiebe S, Tellez-Zenteno J, Shapiro M. An evidencebased approach to the first seizure Epilepsia. 2008; 49 (Suppl. 1): 50-57.10.1111/j.1528-1167.2008.01451.xSearch in Google Scholar

4. Marson A. When to start antiepileptic drug treatment and with what evidence? Epilepsia. 2008; 49 (Suppl. 1): 3-6.10.1111/j.1528-1167.2008.01920.xSearch in Google Scholar

5. Perucca E, Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011; 10: 446-56.10.1016/S1474-4422(11)70047-3Search in Google Scholar

6. Hixson J. Stopping Antiepileptic Drugs: When and Why? Current Treatment Options in Neurology. 2010; 12: 434-442.Search in Google Scholar

7. Camfield P, Camfield C. When is it safe to discontinue AED treatment? Epilepsia. 2008; 49 (Suppl. 9): 25-28.10.1111/j.1528-1167.2008.01923.xSearch in Google Scholar

8. Glauser T, Ben-Menachem E, Bourgeoiset B, et al. ILAE Treatment Guidelines: Evidence-based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes. Epilepsia. 2006; 47(7): 1094-1120.10.1111/j.1528-1167.2006.00585.xSearch in Google Scholar

9. J. A. French, A. M. Kanner, J. Bautista, et al. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Societ Neurology. 2004; 62: 1252-1260.Search in Google Scholar

10. J. A. French, A. M. Kanner, J. Bautista, et al. Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.Search in Google Scholar

11. National Institute for Health and Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care (update). (Clinical guideline 137.)Search in Google Scholar

2012. http://guidance.nice.org.uk/CG137.Search in Google Scholar

12. Beydoun A, D'Souza J. Treatment of idiopathic generalized epilepsy - a review of the evidence. Expert Opin Pharmacother. 2012; 13(9): 1283-98.10.1517/14656566.2012.685162Search in Google Scholar

13. Bourgeois BF. Chronic management of seizures in the syndrom es of idiopathic generalized epilepsy. Epilepsia. 2003; 44 Suppl 2: 27-32.10.1046/j.1528-1157.44.s.2.1.xSearch in Google Scholar

14. S. Noachtar, E. Andermann, P. Meyvisch, F. Andermann, W. B. Gough, J. Schiemann-Delgado, Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures Neurology. 2008; 70(8): 607-616.Search in Google Scholar

15. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 16, 2002; 695-714.10.2165/00023210-200216100-00004Search in Google Scholar

16. Marson A.G, Al-Kharusi A.M, Alwaidh M, Appleton R, Baker G.A, et al. SANAD Study group, 2007. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 369, 1016-1026.10.1016/S0140-6736(07)60461-9Search in Google Scholar

17. Gelisse P, Genton P, Kuate C, Pesenti A, Baldy- Moulinier M, Crespel A. Worsening of Seizures by Oxcarbazepine in Juvenile Idiopathic Generalized Epilepsies. Epilepsia. 2004; 45: 1282-1286. 1. 1.10.1111/j.0013-9580.2004.19704.x15461683Search in Google Scholar

18. Thomas P, Valton L and Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain. 2006; 129, 1281-1292.Search in Google Scholar

19. Lige Liu, Thomas Zheng, Margaret J. Morris, Charlott Wallengren, Alison L. Clarke, Christopher A. Reid, et al. The Mechanism of Carbamazepine Aggravation of Absence Seizures. The Journal of Pharmacology and Experimental Therapeutics. 2006; 319: 790-798.10.1124/jpet.106.10496816895979Search in Google Scholar